NCT03322046

Brief Summary

The purpose of this protocol is to observe whether providing the first responder population with a multi-tiered therapeutic lifestyle modification program, including regular blood testing, diet and telephonic lifestyle coaching, daily food journaling using web-based tools and smartphone apps can lead to positive changes in behavior, resulting in improvements in blood based markers of risk of cardiovascular disease (CVD) as well as improvements in weight and waist circumference.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
185

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2013

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 8, 2013

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 20, 2014

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 8, 2015

Completed
2.8 years until next milestone

First Submitted

Initial submission to the registry

October 18, 2017

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 26, 2017

Completed
Last Updated

October 26, 2017

Status Verified

October 1, 2017

Enrollment Period

1.1 years

First QC Date

October 18, 2017

Last Update Submit

October 24, 2017

Conditions

Keywords

Therapeutic Lifestyle ChangeCardiovascular DiseaseFirst RespondersFirefightersCVD

Outcome Measures

Primary Outcomes (3)

  • Weight loss

    Change in weight from baseline measurement

    12 months

  • Reduction in waist circumference

    Change in waist circumference from baseline measurement

    12 months

  • Increase in large HDL subparticles

    Change in concentration of large HDL particles measured by 2Dimensional gel electrophoresis

    12 months

Secondary Outcomes (1)

  • Improvements in blood based markers of CVD risk

    12 months

Study Arms (2)

Therapeutic Lifestyle Change (TLC) Intervention Group

TLC group received CVD risk lecture, enrolled in lifestyle program, received follow-up visits from team practitioner after each blood draw, access to food journaling portal for 12 month period, telephonic coaching

Behavioral: Lifestyle Program

Control Group

Control group received CVD risk lecture, then baseline, 3, 6, 12 month blood draws and 3 day food journals prior to each blood draw.

Interventions

4 elements: 1) Laboratory test results with diagnostic report describing results, 2) Lifestyle plan generated in online portal with personalized nutritional information based on combination of laboratory results and personal preferences, 3) online or smartphone food journaling application, 4) telephone based lifestyle coaching with Registered Dietitian.

Therapeutic Lifestyle Change (TLC) Intervention Group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

First responders: fire fighters, police officers, EMT personnel

You may qualify if:

  • Low apolipoprotein A-1 (apoA-1) levels in the very large alpha-1 HDL particle (\<20 mg/dL for men, \<30 mg/dL for women) OR increased waist size (at least 40 inches for men or 35 inches for women).
  • Internet access
  • day food log completed prior to initiating the study intervention (or 3-day food log for the control group).

You may not qualify if:

  • No insulin-requiring diabetes
  • No pregnancy or plans to get pregnant in next 12 months
  • Unable or unwilling to follow protocol
  • Unavailable for duration of study
  • Planning to change jobs during study term

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Boston Heart Diagnostics

Framingham, Massachusetts, 01702, United States

Location

Related Publications (8)

  • Asztalos BF, Batista M, Horvath KV, Cox CE, Dallal GE, Morse JS, Brown GB, Schaefer EJ. Change in alpha1 HDL concentration predicts progression in coronary artery stenosis. Arterioscler Thromb Vasc Biol. 2003 May 1;23(5):847-52. doi: 10.1161/01.ATV.0000066133.32063.BB. Epub 2003 Mar 13.

  • Asztalos BF, Cupples LA, Demissie S, Horvath KV, Cox CE, Batista MC, Schaefer EJ. High-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants of the Framingham Offspring Study. Arterioscler Thromb Vasc Biol. 2004 Nov;24(11):2181-7. doi: 10.1161/01.ATV.0000146325.93749.a8. Epub 2004 Sep 23.

  • Kales SN, Soteriades ES, Christophi CA, Christiani DC. Emergency duties and deaths from heart disease among firefighters in the United States. N Engl J Med. 2007 Mar 22;356(12):1207-15. doi: 10.1056/NEJMoa060357.

  • Kales SN, Tsismenakis AJ, Zhang C, Soteriades ES. Blood pressure in firefighters, police officers, and other emergency responders. Am J Hypertens. 2009 Jan;22(1):11-20. doi: 10.1038/ajh.2008.296. Epub 2008 Oct 16.

  • Poston WS, Jitnarin N, Haddock CK, Jahnke SA, Tuley BC. The impact of surveillance on weight change and predictors of change in a population-based firefighter cohort. J Occup Environ Med. 2012 Aug;54(8):961-8. doi: 10.1097/JOM.0b013e31825296e0.

  • Schaefer EJ, Santos RD, Asztalos BF. Marked HDL deficiency and premature coronary heart disease. Curr Opin Lipidol. 2010 Aug;21(4):289-97. doi: 10.1097/MOL.0b013e32833c1ef6.

  • Soteriades ES, Hauser R, Kawachi I, Liarokapis D, Christiani DC, Kales SN. Obesity and cardiovascular disease risk factors in firefighters: a prospective cohort study. Obes Res. 2005 Oct;13(10):1756-63. doi: 10.1038/oby.2005.214.

  • Gill R, Superko HR, McCarthy MM, Jack K, Jones B, Ghosh D, Richards S, Gleason JA, Williams PT, Dansinger M. Cardiovascular Risk Factor Reduction in First Responders Resulting From an Individualized Lifestyle and Blood Test Program: A Randomized Controlled Trial. J Occup Environ Med. 2019 Mar;61(3):183-189. doi: 10.1097/JOM.0000000000001490.

Biospecimen

Retention: SAMPLES WITH DNA

Serum, plasma

MeSH Terms

Conditions

Cardiovascular Diseases

Study Officials

  • Michael Dansinger, MD

    Boston Heart Diagnostics

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 18, 2017

First Posted

October 26, 2017

Study Start

October 8, 2013

Primary Completion

November 20, 2014

Study Completion

January 8, 2015

Last Updated

October 26, 2017

Record last verified: 2017-10

Locations